This secondary data is from an endline survey conducted in 2019 across 12 districts of two northern Indian states– Madhya Pradesh (MP) and Bihar – to evaluate the effectiveness of a mHealth interventi
BackgroundImmunotherapy combined with chemotherapy has improved outcomes in advanced gastric cancer (GC), but reliable biomarkers to predict clinical benefit remain limited. Metabolomics provides a co
